PaNeX: Partial Nephrectomy Under Xenon
NCT01839084 · Status: COMPLETED · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 46
Last updated 2016-02-18
Summary
Purpose of this study is to determine whether Xenon - as compared to Isoflurane - shows a nephroprotection after partial nephrectomy.
Conditions
- Renal Function After Partial Nephrectomy
Interventions
- DRUG
-
Xenon
general anaesthesia with xenon 60% in oxygen (FiO2=0.4)
- DRUG
-
Isoflurane
general anesthesia with isoflurane 1.2% in 40% oxygen/medical air
Sponsors & Collaborators
-
German Research Foundation
collaborator OTHER -
RWTH Aachen University
lead OTHER
Principal Investigators
-
Astrid Fahlenkamp, Dr. med. · Department of Anesthesiology, University Hospital Aachen
Study Design
- Allocation
- RANDOMIZED
- Purpose
- TREATMENT
- Masking
- QUADRUPLE
- Model
- PARALLEL
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2013-07-31
- Primary Completion
- 2016-02-29
- Completion
- 2016-02-29
Countries
- Germany
Study Locations
More Related Trials
-
Acetylcysteine, Theophylline, and a Combination of Both in the Prophylaxis of Contrast-Induced Nephropathy
NCT00492518 ·Status: COMPLETED ·Phase: PHASE4
-
Acute Renal Failure Post Liver Transplantation
NCT01907061 ·Status: COMPLETED ·Phase: NA
-
Optimalization of Nephroprotection Using N-Acetylcysteine
NCT00572663 ·Status: COMPLETED ·Phase: NA
-
A Study of The Effectiveness of N-Acetylcysteine in Kidney Protection Following Cardiopulmonary Bypass
NCT00187330 ·Status: COMPLETED ·Phase: PHASE2
-
Comparison Between Effect of Acetazolamide and NaHco3 in Prevention of Contrast Nephropathy
NCT00634491 ·Status: COMPLETED ·Phase: PHASE2
-
NOX-100 for Preventing Hypotension During Hemodialysis
NCT01672008 ·Status: COMPLETED ·Phase: PHASE2
-
Study of the Effect of N-acetyl Cysteine on the Renal Graft Function Biomarkers (IL18, NGAL)
NCT01403506 ·Status: UNKNOWN ·Phase: PHASE3
-
N-acetylcysteine for Renal Protection in Patients With Rheumatic Heart Disease Undergoing Valve Replacement
NCT01704482 ·Status: COMPLETED ·Phase: PHASE2
-
Intravenous Amino Acid Therapy for Kidney Protection in Cardiac Surgery.
NCT03709264 ·Status: COMPLETED ·Phase: PHASE3
-
Acetylcysteine Against Acute Renal Insult During Cardiopulmonary Bypass.
NCT00190034 ·Status: SUSPENDED ·Phase: PHASE4
-
Renal PRotection Against Contrast mEdium-induced nephroPathy in High Risk Patients undErgoing Coronary Angiography
NCT02463604 ·Status: COMPLETED ·Phase: NA
-
N-Acetylcysteine for Preventing Renal Injury After Cardiac Surgery
NCT00188630 ·Status: COMPLETED ·Phase: PHASE3
-
Pharmacodynamics Aspects Of Porcine Heparin Sodium, Produced by Eurofarma, Compared Heparin Sodium, Produced by APP Pharmaceuticasls, in Patients With Chronic Renal Failure
NCT01034488 ·Status: UNKNOWN ·Phase: PHASE2/PHASE3
-
Ioxaglate Versus Iodixanol for the Prevention of Contrast-induced Nephropathy in High-risk Patients (IDPC Trial)
NCT02991742 ·Status: UNKNOWN
-
Inorganic Nitrate (NaNO3) Prevention of Contrast-Associated Acute Kidney Injury
NCT07016074 ·Status: RECRUITING ·Phase: PHASE2
-
Impact of N-Acetylcysteine on Oxidative Stress and Renal Function in Deceased Kidney Transplant Recipients
NCT00851708 ·Status: COMPLETED ·Phase: NA
-
Evaluation of the Effects of L-Carnitine Injection in Patients Undergoing Hemodialysis
NCT00173706 ·Status: UNKNOWN ·Phase: PHASE4
-
Preventive Effect of Pitavastatin on Contrast-Induced Nephropathy in Patients With Renal Dysfunction
NCT01871792 ·Status: UNKNOWN ·Phase: PHASE4
-
Ischemic Preconditioning to Prevent Acute Kidney Injury
NCT02167152 ·Status: COMPLETED ·Phase: NA
-
Evaluating the Protective Effect of Pentoxifylline on Contrast Induced Nephropathy
NCT01469624 ·Status: UNKNOWN ·Phase: NA
-
The Risks of Percutaneous Native Kidney Biopsy in Italy: a Prospective Cohort Study
NCT04948593 ·Status: COMPLETED
-
The Effect of Dexmedetomidine on Kidney Function in EVAR
NCT04766047 ·Status: UNKNOWN ·Phase: NA
-
Prevention of Acute Kidney Injury by N-Acetylcystein in Patients Undergone Cardiac Valve Replacement
NCT03440268 ·Status: UNKNOWN ·Phase: PHASE4
-
Methylene Blue for the Prevention of Hypotension During Hemodialysis
NCT05092165 ·Status: COMPLETED ·Phase: PHASE2
-
Effect of the Amino Acid L-arginine on Perioperative Cardio-vascular Risk in Non-selected Patients
NCT01413815 ·Status: COMPLETED ·Phase: NA